Addressing methodological concerns in omega-3 trial for bipolar disorder relapse prevention.
Psychiatry Res
; 337: 115947, 2024 Jul.
Article
em En
| MEDLINE
| ID: mdl-38733931
ABSTRACT
Our response addresses concerns raised about our pilot trial on omega-3 for bipolar disorder. We clarify randomization procedures, highlight the benefits of eicosapentaenoic-predominant formulations for a specific bipolar patients subgroup, and justify the use of Kaplan-Meier analysis despite limitations. We acknowledge analytical challenges due to strict inclusion criteria and encourage future research on specific bipolar subtypes and larger-scale trials for robust validation.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Transtorno Bipolar
/
Ácidos Graxos Ômega-3
/
Prevenção Secundária
Limite:
Humans
Idioma:
En
Revista:
Psychiatry Res
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Nigéria